Library — CHDR

Search

Filter

Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humans.

Hoch M, Hay JL, Hoever P, de Kam ML, te Beek ET, van Gerven JM, Dingemanse J

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013 Jan; 23(2):107-17

View publication
Orexin receptor antagonism: an ascending multiple-dose study with almorexant.

Hoever P, de Haas SL, Dorffner G, Chiossi E, van Gerven JM, Dingemanse J

Journal of psychopharmacology (Oxford, England), 2012 Jul; 26(8):1071-80

View publication
Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant.

Hoever P, de Haas S, Winkler J, Schoemaker RC, Chiossi E, van Gerven J, Dingemanse J

Clinical pharmacology and therapeutics, 2010 Apr; 87(5):593-600

View publication
Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625.

Zuurman L, Roy C, Schoemaker RC, Amatsaleh A, Guimaeres L, Pinquier JL, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2010 Feb; 24(3):363-71

View publication
Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy.

de Haas S, Otte A, de Weerd A, van Erp G, Cohen A, van Gerven J

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2007 Aug; 3(5):473-8

View publication
Promotion of sleep by targeting the orexin system in rats, dogs and humans.

Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F

Nature medicine, 2007 Jan; 13(2):150-5

View publication
Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life.

de Weerd A, de Haas S, Otte A, Trenité DK, van Erp G, Cohen A, de Kam M, van Gerven J

Epilepsia, 2004 Oct; 45(11):1397-404

View publication
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.

Rijnbeek B, de Visser SJ, Franson KL, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2003 Jun; 17(2):196-203

View publication
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.

Karlsson MO, Schoemaker RC, Kemp B, Cohen AF, van Gerven JM, Tuk B, Peck CC, Danhof M

Clinical pharmacology and therapeutics, 2000 Jul; 68(2):175-88

View publication

«
1
2
3
4
»